Analgesics (Pharmacies) - North America

Revenue in the Analgesics market is projected to reach US$5.07bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.51%, resulting in a market volume of US$6.32bn by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$9.94 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in North America is experiencing steady growth due to several factors.

Customer preferences: Customers in North America have a strong preference for over-the-counter analgesics that provide quick and effective relief from pain. They value convenience and accessibility, often choosing to purchase these products from pharmacies rather than seeking a prescription from a healthcare professional. Additionally, customers are increasingly seeking natural and organic alternatives to traditional analgesics, driving the demand for herbal and homeopathic remedies.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in North America is the growing popularity of online pharmacies. With the rise of e-commerce, customers are now able to conveniently purchase analgesics from the comfort of their own homes. This trend is particularly prevalent among younger consumers who are tech-savvy and value the convenience of online shopping. Another trend in the market is the increasing demand for personalized pain relief solutions. Customers are looking for products that are tailored to their specific needs and preferences. This has led to the development of analgesics that target specific types of pain, such as migraines or joint pain. Manufacturers are also investing in research and development to create innovative delivery systems, such as patches or gels, that provide targeted pain relief.

Local special circumstances: The Analgesics (Pharmacies) market in North America is highly competitive, with several major players dominating the market. These companies invest heavily in marketing and advertising to promote their products and maintain brand loyalty. Additionally, the market is regulated by strict government guidelines and regulations, ensuring the safety and efficacy of analgesics sold in pharmacies.

Underlying macroeconomic factors: The growing aging population in North America is a significant macroeconomic factor driving the growth of the Analgesics (Pharmacies) market. As people age, they are more likely to experience chronic pain conditions, such as arthritis or back pain, and require regular pain relief medication. This demographic shift is expected to continue in the coming years, further fueling the demand for analgesics. Another macroeconomic factor is the increasing healthcare expenditure in North America. As people become more conscious of their health and well-being, they are willing to spend more on healthcare products, including analgesics. This trend is particularly evident in the United States, where healthcare costs are high and individuals are responsible for a significant portion of their healthcare expenses. In conclusion, the Analgesics (Pharmacies) market in North America is growing steadily due to customer preferences for convenience and accessibility, the popularity of online pharmacies, and the increasing demand for personalized pain relief solutions. The market is highly competitive, regulated by strict government guidelines, and influenced by the growing aging population and increasing healthcare expenditure in the region.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.